Key Highlights
- With a new USD 6.50 objective, Treace Medical Concepts shows the largest gap to the trading level, roughly 61.3% over the USD 4.03 price seen on November 6.
- Unum Group climbed 5.19% to USD 80.74 after a move to Overweight, even though the price target was lowered to USD 90 from USD 98.
- Upgrades lifted Tripadvisor and Airbnb to Hold and Neutral, but the revised objectives for both hover near the prices at which the stocks currently trade.
- Tronox earned a shift to Neutral from Underweight near USD 2.51, and its target was pulled, which makes it the most cautious upgrade in the list.
1. Treace Medical Concepts (NASDAQ:TMCI) Operating Momentum
A research call on November 9, 2026 moved Treace Medical Concepts (NASDAQ:TMCI) to Buy from Hold and lifted the target from USD 4.50 to USD 6.50. Relative to the USD 4.03 close recorded on November 6, that objective embeds roughly 61.3% of upside, the widest figure among the five. The argument leans on operating momentum more than on valuation. The third quarter of 2026 delivered a twelfth straight top-line beat, and adjusted EBITDA reached USD 0.3 million, the first positive result for a quarter other than the fourth since the company's 2021 debut. The analyst believes a fresh product wave can sustain sales growth and keep EBITDA climbing. The principal objection is that the rally already happened: the shares doubled over the half-year before the call, so this extends a run rather than marking a reversal, and the new products must deliver through 2027.
2. Unum Group (NYSE:UNM) Valuation Case
Unum Group (NYSE:UNM) gained 5.19% to USD 80.74 in late-morning trading on November 9 once a large US bank raised its rating to Overweight from Neutral. The bank reduced its objective to USD 90 from USD 98, yet argues that risk-reward remains favorable even on trimmed forecasts, a view that suggests about 11% upside. Valuation sits at the core of the note. Pricing stands at roughly 9.6 times the center of the 2026 adjusted Operating Income range, USD 8.30 to USD 8.50 per share. The rating change followed a steep sell-off after third-quarter numbers that included a net loss of USD 2.65 per share, driven by a USD 853 million hit from investments. This is a contrarian stance: the bank bets that the hit leaves the Earnings foundation untouched and that strong Capital and stable headcount trends persist. Disability margins and long-term care exposure are the principal hazards to that thesis.
3. Tripadvisor (NASDAQ:TRIP) Limited Downside
Tripadvisor (NASDAQ:TRIP) moved up to Hold from Underperform on November 9, while its target was pared to USD 7.00 from USD 8.00. The shares are hovering close to a 52-week trough of USD 6.95, so the lowered objective offers scant room for appreciation. Backers of the change point to two things: the valuation is the least demanding among rivals, and growing activist involvement might act as a trigger. Forecasts within the same note were marked down, with 2028 Revenue cut by roughly 3% and 2028 EBITDA by about 10%, primarily because the Experiences segment is expanding more slowly. Current conditions are unfavorable. Third-quarter revenue reached USD 436.4 million and adjusted earnings reached USD 0.37 per share, both below projections of USD 453.2 million and USD 0.45, while fourth-quarter revenue is seen dropping at a low-teens rate. This is a bet on limited downside, not on a revival in growth.
4. Airbnb (NASDAQ:ABNB) Price Versus Target
A European brokerage elevated Airbnb (NASDAQ:ABNB) to Neutral from Sell on November 9, with its target climbing to USD 190 from USD 135. The house conceded that its bearish stance had worked for six years but failed over the past year. Q3 numbers changed the outlook: sales advanced 16% to USD 4.9 billion and bookings rose 21% to USD 27.7 billion on a constant currency basis, a result the house reads as preparation for accelerated growth in the core operation. Entry is the sticking point. The stock was trading near USD 189.99, not far from a 52-week peak of USD 193.45, after a 57% rise across the last year, leaving almost nothing to gain relative to the new objective. Removing one of the last Sell labels could buoy sentiment, though the move looks more like surrender than conviction.
5. Tronox Holdings (NYSE:TROX) Sell-off Priced In
Tronox Holdings (NYSE:TROX) received a move up to Neutral from Underweight on November 9, while the research house dropped its December 2027 objective. Shares sat around USD 2.51, a whisker above a 52-week floor of USD 2.42 and roughly 71% lower over half a year. Preliminary readings hinted at a 7% advance after the note, though that estimate stems from sparse trading information. The write-up itself is gloomy, pointing to soft Demand and mounting costs, including European natural gas, freight and oil-derived inputs. Adjusted results for the third quarter came in at a loss of USD 0.34 per share versus an anticipated loss of USD 0.20, on revenue of USD 827 million, and the note expects 2026 free Cash Flow of about negative USD 72 million once dividends are counted. Upgrading signals that the sell-off has absorbed much of the bad news rather than that the Business is recovering.
Where Things Stand
Treace Medical Concepts has the largest upside among the five analyst upgrades of November 9, with a USD 6.50 objective about 61.3% above its previous close and twelve straight revenue beats behind it. Unum Group presents roughly 11% upside built on valuation after a third-quarter loss. Tripadvisor, Airbnb and Tronox merely swap bearish labels for neutral ones, since their objectives hug current prices or, for Tronox, have been removed. Each call came after a large swing, a surge at Treace and Airbnb and a drop at Unum, Tripadvisor and Tronox, so the forthcoming quarterly updates will show whether timing was on the mark.






Please wait processing your request...